Thomas Odonnell

Healthcare Market Director - Neurological Rare Disease @Genentech

Chicago, IL, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2020 — Present

Healthcare Market Director - Neurological Rare Disease @Genentech

View department →

US

Lead a cross functional team of Neuro Rare Disease Specialists (NRDs) and Partnership and Access Liaisons (PALs) with clinical and access responsibilities supporting the mission of removing barriers to care for patients in rare disease. The Neuro Rare Disease Team successfully launched Risdiplam for the treatment of Spinal Muscular Atrophy (SMA) to Health Care Providers and Patients in Ohio, Pennsylvania Indiana and Illinois.

EDUCATION

1979 — 1983

University of Dayton

BS, Biology & Chemistry

1995 — 1998

Keller Graduate School of Management of DeVry University

Masters, Master of Project Management 1998. Master of Business Administration 1997

ABOUT THOMAS ODONNELL

Biotechnology people leader and account management professional with extensive experience building and leading rare disease, field reimbursement and account management teams and in establishing long-term strategic relationships with Government Payers (Medicare, Medicaid) Group Purchasing Organizations (GPO), Hospital Systems, National Pharmacy Benefit Managers (PBM), Regional Health Plans and Specialty Pharmacies. An authentic, servant leader who has led successfully across multiple therapeutic areas and cross functional teams. Well known in the organization for his passion and commitment to people, ability to inspire and coach teams, collaborate to achieve consistent results and experience launching and building new markets. Extensive experience in Access and Reimbursement, engaging with customers and leading teams across account management, sales, and training and development.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.